The role of satisfaction with care among factors affecting health-related quality of life in people with cancer: a cross-sectional study [0.03%]
一项横断面研究：影响癌症患者生命质量的护理满意度作用因素分析
Federica Sancassiani,Goce Kalcev,Mirian Agus et al.
Federica Sancassiani et al.
Background: Despite advances in therapies that have increased the duration of post-diagnosis survival, living with long-term adverse effects of cancer and its treatment is common. This study aims to evaluate satisfaction ...
Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinoma [0.03%]
个例报告：卡博替尼和派姆单抗治疗三线胰腺导管腺癌患者的疗效分析
Anna M Reagan,Hannah G McDonald,Jaewon Kang et al.
Anna M Reagan et al.
Immunotherapy has yet to demonstrate durable efficacy in pancreatic ductal adenocarcinoma (PDAC) despite the fact that pancreatic cancer cells have higher levels of immune checkpoint expression than other cancer cell types in which immunoth...
Case report: A case of mast cell leukemia treated with avapritinib: from diagnostic challenge to transplantation [0.03%]
个例报告：伊马替尼联合阿伐普利尼治疗的肥大细胞白血病一例：从诊断难题到移植挑战
Danilo Giuseppe Faraci,Daniela Caravelli,Fabrizio Carnevale Schianca et al.
Danilo Giuseppe Faraci et al.
Systemic mastocytosis (SM) is a rare hematological neoplasm characterized by the proliferation and accumulation of clonal mast cells (MCs) in the skin, bone marrow, and other extracutaneous organs. Mast cell leukemia (MCL) is the rarest and...
Chemotherapy-induced gut microbiota dysbiosis exacerbates cancer-related fatigue in breast cancer patients via neuroimmune-endocrine indicators [0.03%]
化疗诱导的肠道菌群失调通过神经免疫内分泌指标加重乳腺癌患者的癌症相关疲劳感
Fengxia Lai,Yang Yuan,Haiyan Dong et al.
Fengxia Lai et al.
Background: Breast cancer patients frequently experience debilitating cancer-related fatigue (CRF) during chemotherapy. Emerging evidence implicates the gut microbiota (GM) and the gut-brain axis in CRF pathogenesis, yet ...
Case Report: Mixed ductal-lobular carcinoma consisting of invasive lobular carcinoma with a glycogen-rich clear cell pattern and elevated tumor mutation burden [0.03%]
病例报告：由富含糖原的透明细胞型浸润性小叶癌组成的混合导管小叶癌及升高的肿瘤突变负荷
Kae Kawachi,Xiaoyan Tang,Rika Kasajima et al.
Kae Kawachi et al.
Background: Mixed ductal-lobular carcinoma (MDL) of the breast exhibits considerable molecular complexity. The pathways leading to the glycogen-rich clear cell morphology of the breast tumors, and its clinical relevance, ...
Clinical diagnosis and treatment analysis of 11 cases of unicentric Castleman disease in the retroperitoneum [0.03%]
后腹膜原发单一中心性Castleman病的临床诊断和治疗分析
Ke Dong,Hongyu Zhang,Lunan Wu et al.
Ke Dong et al.
Objective: To investigate the diagnosis, treatment, and prognosis of unicentric Castleman disease (UCD) located in the retroperitoneum. Methods: ...
Commentary: Grading of clear cell renal cell carcinoma using diffusion MRI with a multimodal apparent diffusion model [0.03%]
基于多模态表观扩散模型的透明细胞肾癌分级的弥散加权磁共振成像定量研究
Jing Chen,Pengpeng Huang,LiFang Yang
Jing Chen
Jugular foramen tumor causing isolated hypoglossal nerve palsy: a case report [0.03%]
jugular ForAMen肿瘤引起的孤立性舌下神经麻痹：1例报告
Zhijun Wen,Youcheng Li,Jianhua Cheng et al.
Zhijun Wen et al.
Background: The etiology of hypoglossal nerve palsy is diverse, including trauma, infection, tumors, endocrine disorders, autoimmune diseases, and vascular lesions. Tumors in the jugular foramen region are rare and primar...
Suicide risk and mortality among patients with cancers of the digestive system: a systematic review and meta-analysis [0.03%]
消化系统癌症患者的自杀风险和死亡率：系统回顾和meta分析
Yebin Wang,Xiaotian Yang,Mengyao Song et al.
Yebin Wang et al.
Background: Although significant strides have been made in cancer therapy, studies show that suicide rates among digestive cancer patients compared to the general population remain controversial, and specific risk factors...
Correction: Vitiligo associated with ribociclib therapy: a rare case report [0.03%]
更正：与瑞波西利治疗相关的白癜风：一例罕见病例报告
Zirui Wang,Yuanrui Bai,Rihan Wu et al.
Zirui Wang et al.
[This corrects the article DOI: 10.3389/fonc.2025.1669407.]. Keywords: CDK4/6 inhibitor; breast cancer; immu...
Published Erratum
Frontiers in oncology. 2026 Jan 26:16:1790586. DOI:10.3389/fonc.2026.1790586 2026